Skip to main content

MoneyWorks4Me

Paras Healthcare Ltd (PARASHLTH)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 545005 NSE: PARASHLTH Hospital & Healthcare Services | Small Cap | Paras Healthcare Share Price

₹882.35 76.05 (9.43%)

As on 12-Nov'26 16:59

Paras Healthcare Ltd (PARASHLTH)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 545005 NSE: PARASHLTH Hospital & Healthcare Services | Small Cap | Paras Healthcare Share Price

₹882.35 76.05 (9.43%)

As on 12-Nov'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹8,724 Cr.
Current Price
₹882.4
52-Week Low / High
₹706 / 812
TTM EPS
₹4.1
TTM Sales
₹1,606 Cr.
Book Value per Share
₹91.1
P/E Ratio
199.03
Industry PE
92.5
Price to Book (P/B)
8.85
Price to Sales (P/S)
5.43
EV/EBITDA
27.74
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
12.99%
Outperforms industry median
Return on Capital Employed (ROCE)
17.30%
Outperforms industry median
Return on Assets (ROA)
2.26%
Underperforms industry median
Operating Profit Margin
19.8%
In line with industry median
Net Profit Margin
2.73%
Underperforms industry median
Gross Profit Margin
13.7%
Underperforms industry median
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
20.36%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
126.87%
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
63.95%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹975 Cr.
Equity
₹10.8 Cr.
Face Value
₹1
All Time Low / High
₹705.75 / 794.75

Paras Healthcare stock performance

Key Ratios
mw4me loader

Check Before You Invest

Valuation

NA

Price Trend

Weak
Q.1 Is Paras Healthcare Ltd a good quality company?
Paras Healthcare Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Paras Healthcare Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Paras Healthcare Ltd vs industry peers?
Paras Healthcare Ltd revenue CAGR is 21.83%, compared to the industry median CAGR of 0.00%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Paras Healthcare Ltd?
Promoters hold 63.95% of the Paras Healthcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Paras Healthcare Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Paras Healthcare Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
ROCE % ⓘ8.6%19.4%12.5%10.3%6.9%15.2%14.9%20%8.9%17.4%-
Value Creation
Index ⓘ
-0.40.4-0.1-0.2-0.50.10.10.5-0.40.2-

Growth Parameters ⓘ

Sales ⓘ4124694985755977768791,0101,1371,3681,368
Sales YoY Gr.-13.7%6.3%15.3%3.9%30%13.3%14.9%12.5%20.4%-
Adj EPS ⓘ0.264.31.60.24.85.17.10.39.28.6
YoY Gr.-3227.8%-28.6%-62.4%-89.4%2717.7%7.3%37.6%-95.2%2617.7%-
BVPS (₹) ⓘ8.912.917.11816.717.417.553.453.868.1116.9
Adj Net
Profit ⓘ
1.344.831.511.81.235.237.8693.493.393
Cash Flow from Ops. ⓘ30.727.330.5-6.385.883.166.7125112176-
Debt/CF from Ops. ⓘ4.112.111.5-17.82.32.44.63.45.44.2-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ14.3%18%15.9%20.4%
Adj EPS ⓘ54.9%122.4%21.6%2617.7%
BVPSⓘ25.3%32.4%57.3%26.7%
Share Price - - - -

Key Financial Parameters ⓘ

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
Return on
Equity % ⓘ
255.428.69.2128.129.421.20.615.49.3
Op. Profit
Mgn % ⓘ
8.812.211.18.39.715.715.414.213.121.221.3
Net Profit
Mgn % ⓘ
0.39.66.32.10.24.54.36.80.36.86.8
Debt to
Equity ⓘ
1.93.52.80.81.61.52.40.81.21.10.5
Working Cap
Days ⓘ
10010411315815110814015217619184
Cash Conv.
Cycle ⓘ
-56-65-60-53-28-24-6711143

Valuation of Paras Healthcare - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Sales4694985755987809181,1291,2941,606
Operating Expenses ⓘ + 4124435315627098461,0081,1551,290
Manufacturing Costs16518329247297348397512542
Material Costs105110129155205236297337430
Employee Cost 70728886100134167174182
Other Costs ⓘ 717928473106128146132136
Operating Profit ⓘ 575544367171121139316
Operating Profit Margin (%) 12.2%11.0%7.7%6.1%9.1%7.8%10.8%10.8%19.7%
Other Income ⓘ + 332730171318352023
Exceptional Items ⓘ -9-10230000
Interest ⓘ 1210263233516994119
Depreciation ⓘ 21254445516581116144
Profit Before Tax ⓘ 48464-213-277-5076
Tax ⓘ 91654181622832
Profit After Tax 3930-0-25-15-43-15-5844
PAT Margin (%) 8.2%6.0%-0.1%-4.2%-1.9%-4.7%-1.4%-4.5%2.7%
Adjusted EPS (₹)5.34.1-0.1-3.5-2.0-5.8-1.6-5.94.3
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26

Equity and Liabilities

Shareholders Fund + 95125113887330339280395
Share Capital ⓘ 3.683.683.683.683.683.689.769.7610.10
Reserves ⓘ 91121110846926329271385
Debt +313333111181191362507664778
Long Term Debt30431774122139255358436454
Short Term Debt916375952107148228323
Minority Interest000000000
Trade Payables676785101119124137191208
Others Liabilities ⓘ 5556433437580777495675691
Total Liabilities ⓘ 5305817428079641,2931,4781,8102,071

Fixed Assets

Net Fixed Assets ⓘ +1261804274144867809881,1731,211
Gross Block1442235145326369821,2571,5451,699
Accumulated Depreciation184387118151202269371488
CWIP ⓘ 3713154178293829
Investments ⓘ 201220000000
Inventories131517111218282632
Trade Receivables4850494284131156235350
Cash Equivalents 51965254198162160206303
Others Assets ⓘ 10010424480142125117133148
Total Assets ⓘ 5305817428079641,2931,4781,8102,071
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Cash Flow From Operating Activity ⓘ + 3136328482449286164
PBT ⓘ 48464-213-277-5076
Adjustment ⓘ 14225490122163129207250
Changes in Working Capital ⓘ -20-17-824-21-60-33-61-109
Tax Paid ⓘ -12-15-16-9-22-32-11-10-54
Cash Flow From Investing Activity ⓘ + -234-48-13-74-129-126-194-147-239
Capex -40-50-77-56-138-112-195-135-169
Net Investments -196-20-30-1-22-8-23-86
Others ⓘ 25641210881215
Cash Flow From Financing Activity ⓘ + 20519-2551-1197948386
Net Proceeds from Shares ⓘ 0000000069
Net Proceeds from Borrowing ⓘ -1421052248511110231
Interest Paid ⓘ -10-9-18-11-14-42-58-98-109
Dividend Paid ⓘ 000000000
Others ⓘ 2297-610-2054417995
Net Cash Flow ⓘ 27-660-5715-82210
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Ratios
ROE (%)40.7427.35-0.42-25.16-18.37-82.92-8.32-18.7312.99
ROCE (%)14.0512.398.624.0712.696.7711.614.6317.3
Asset Turnover Ratio0.890.90.870.770.880.810.820.790.83
PAT to CFO Conversion(x)0.791.2N/AN/AN/AN/AN/AN/A3.73
Working Capital Days
Receivable Days37.2035.9031.4027.6029.6042.8046.4055.1066.40
Inventory Days9.9010.10108.405.5067.407.606.60
Payable Days230.60222.40214.60218.60195.50187.60160.70177.70169.10

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Annual reports

No annual reports available.

Concalls

No concalls available.

Paras Healthcare Ltd FAQs

The current trading price of Paras Healthcare on 12-Nov-2026 16:59 is ₹882.4.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 11-Nov-2026 the market cap of Paras Healthcare stood at ₹8,724.3 Cr

The latest P/E ratio of Paras Healthcare as of 11-Nov-2026 is 94.06.

The latest P/B ratio of Paras Healthcare as of 11-Nov-2026 is 6.90.

The 52-week high of Paras Healthcare is ₹812.0 and the 52-week low is ₹705.8.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Paras Healthcare is ₹1,368 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Paras Healthcare Ltd is a below average quality company.

No data found

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Paras Healthcare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Paras Healthcare Ltd

Paras Healthcare was incorporated as ‘Arbian Frozen Foods Private Limited’, a private limited company under the provisions of the Companies Act, 1956, pursuant to a certificate of incorporation dated December 21, 1987, issued by the Registrar of Companies, Delhi & Haryana at New Delhi.

The company is a clinical specialty-led hospital platform providing tertiary and quaternary healthcare services. It operates under the “Paras Health” brand. The company operates its hospitals through a mix of owned, leased, revenue-sharing and public-private partnership models, and have adopted a calibrated approach to capital deployment, evaluating capital-efficient structures selectively based on market characteristics, capital efficiency considerations and long-term operating control. The company’s leased facilities are structured through fixed rent, revenue sharing or hybrid arrangements comprising a partial fixed rent and a partial revenue share. Its growth decisions are guided by defined return thresholds and the strength of its balance sheet.

The company’s hospitals have modern operating theatres (OTs), procedure rooms and intensive care units (ICUs) built to rigorous design, safety and technology standards. These facilities are underpinned by advanced equipment from globally reputed manufacturers, including biplane cath labs, MRI machines, radiotherapy systems, linear accelerators (LINACs), surgical robots, PET-CT scanners, neuro and ortho navigation systems, O-arm surgical imaging systems, endoscopic ultrasound (EUS) and endobronchial ultrasound (EBUS) systems, and are built to deliver complex care at scale. The company’s critical care infrastructure spans organ and condition-specific ICUs, enabling focused and protocol-driven care. It operates dedicated cardiac, neuro, liver transplant, kidney transplant, bone marrow transplant, extracorporeal membrane oxygenation (ECMO)-enabled, neonatal, paediatric, medical and surgical ICUs. For immuno-compromised and post-transplant patients, it maintains dedicated ICU rooms equipped with laminar airflow systems and strict infection-control protocols to minimise the risk of cross-infection. 

Business area of the company

The company is a leading clinical specialty-led hospital platform providing tertiary and quaternary healthcare services under the ‘Paras Health’ brand. The company operates its hospitals through a mix of owned, leased, revenue-sharing and public-private partnership models, and have adopted a calibrated approach to capital deployment, evaluating capital-efficient structures selectively based on market characteristics, capital efficiency considerations and long-term operating control.

Awards, accreditations or recognitions

  • 2009: Paras Hospital, Gurugram was the first hospital in Haryana to receive the accreditation by the National Accreditation Board for Hospital & Healthcare Providers.
  • 2009: Accreditation for Paras Hospitals – Laboratory Sciences, Gurugram by the National.
  • 2009: Accreditation Board for Testing and Calibration Laboratories.
  • 2015: Paras HMRI Hospital, Patna received the certificate of recognition for being “First Multi Specialty Hospital in Bihar Jharkhand Region” at the 5th Elets Healthcare Leaders Forum Bengal, 2015.
  • 2016: Paras HMRI Hospital, Patna was awarded ‘Maximum Outreach Hospital of the Year’ by Assocham, India.
  • 2016: Paras HMRI Hospital, Patna was the first hospital in Bihar to receive the accreditation by the National Accreditation Board for Hospital & Healthcare Providers.
  • 2018: Paras HMRI Hospital, Patna was awarded in the “Super Speciality Hospital” category at the Assocham National Leadership Excellence Awards 2018 by Assocham, India.
  • 2019: Paras HMRI Hospital, Patna was awarded “Best Multispeciality Hospital” by Assocham.
  • 2021: Awarded “Best Hospital for COVID Care” by 11th MT Healthcare Awards.
  • 2021: Paras Hospitals, Udaipur received the “Responsible Recycler Certificate” from Greenscape Eco Management Private Limited for handing over e-waste for the purpose of sound e-waste recycling.
  • 2021: Paras Hospital, Gurugram was awarded the silver award in the “Women Health Brand” category at the 7th IHW Awards 2021 by IHW Council.
  • 2021: Accreditation for Paras Hospital, Panchkula by the National Accreditation Board for Hospital & Healthcare Providers.
  • 2021: Accreditation for Paras Hospital, Udaipur by the National Accreditation Board for Hospital & Healthcare Providers.
  • 2021: Paras Global Hospital, Darbhanga received certification for complying with NABH entry level hospital requirement by the National Accreditation Board for Hospital & Healthcare Providers.
  • 2022: Paras HMRI Hospital, Patna was awarded “Best Clean Energy Initiative in Healthcare (Best Energy Saving Hospital)” at the “The Business Tycoon Award”.
  • 2022: Paras HMRI Hospital, Patna was awarded “Most Advanced Hospital” at the “The Business Tycoon Award”.
  • 2022: Paras HMRI Hospital, Patna received the “Service Excellence Award” by Prabhat Khabar Sanjeevani Awards-2022.
  • 2023: Paras Hospital, Panchkula, received the Award for “Leading hospital in Advanced Technologies” by the MY FM at MY FM Excellence Award.
  • 2024: Received the GOLD award for Hospital with Best Adaptation to Digital Health Technology at 3rd IHW Digital Health Awards, 2024 by the IHW Council.
  • 2024: Recognised as ‘one of the Best Healthcare Brands-2024’ by ET Edge.
  • 2024: Paras Health, Panchkula, was awarded the ‘Excellence in Cardiac & Cancer Care’ at the Red Achievers Award, 2024 by Red FM.
  • 2024: Accreditation for Paras HEC Hospital, Ranchi by the National Accreditation Board for Hospital & Healthcare Providers.
  • 2024: Paras Hospital, Gurugram received the Gold award for ‘Smart & Future-Ready Neurology Hospital' by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
  • 2024: Paras HMRI Hospital, Patna received the Silver award for ‘Smart & Future-Ready ER & Critical Care Hospital’ by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
  • 2024: Paras Hospital, Panchkula received the Silver award for ‘Smart & Future-Ready Cancer Hospital’ by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
  • 2024: Paras Global Hospital, Darbhanga received the Gold award for ‘Smart and Future-ready Nephrology care Hospital’ by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
  • 2024: Paras HEC Hospital, Ranchi received the Silver award for ‘Smart & Future-Ready OBS & Gynae Hospital’ by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
  • 2024: Paras Hospital, Srinagar received the Bronze award for ‘Smart & Future-Ready Heart Care Hospital’ by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
  • 2024: Paras Hospital, Udaipur received the Bronze award for ‘Robotics for Patient Care’ by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
  • 2024: The company received the Gold award for ‘Smart & Future Ready Multi Speciality Hospital Chain’ by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
  • 2024: The company received the Gold award for ‘Smart & Future Ready Hospital Management’ by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
  • 2024: Paras Yash Kothari Hospital, Kanpur received the Gold award for ‘Patient Centric Smart Hospital Design’ by the IHW Council at the IHW Smart Hospitals & Diagnostics Awards.
  • 2024: Paras Hospital, Gurugram ranked No. 6 in Bariatrics in Faridabad and Gurgaon City in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
  • 2024: Paras Hospital, Gurugram ranked No. 4 nationally in Orthopedics in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
  • 2024: Paras Hospital, Gurugram ranked No. 3 in Orthopedics in the North Region in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
  • 2024: Paras Hospital, Gurugram ranked No. 1 in Orthopedics in Faridabad and Gurgaon City in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
  • 2024: Paras Hospital, Gurugram ranked No. 8 in Ophthalmology in Faridabad and Gurgaon City in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
  • 2024: Paras Hospital, Gurugram ranked No. 7 in Diabetology in Faridabad and Gurgaon City in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
  • 2024: Paras Hospital, Panchkula ranked No. 6 nationally in Plastic Surgery in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
  • 2024: Paras Hospital, Panchkula ranked No. 4 in Plastic Surgery in the North Region in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
  • 2024: Paras Hospital, Gurugram ranked No. 5 nationally in IVF and Fertility in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
  • 2024: Paras Hospital, Gurugram ranked No. 2 in IVF and Fertility in the North Region in the All India Lifestyle Hospital & Clinic Ranking Survey 2024 by Times Health Survey.
  • 2025: Paras Hospital, Kanpur was awarded “Best Multi Speciality Hospital in Kanpur” award at the Big Impact Awards, 2025.
  • 2025: Paras Health Group ranked No. 4 - National in the “Multi-Speciality Group of Hospital” category by Times Now Health Ranking Survey at the India Health Summit & Awards, 2025.
  • 2025: Paras Health Group was awarded as “Lead 50 Cybersecurity (North Based HO)” category by Alden Global's Cyber Security & Tech.
  • 2025: Paras Hospital, Panchkula was awarded as “Pioneer in Leading Hospital in Neurosciences” by Times of India.
  • 2025: Paras Hospital, Panchkula was awarded “Excellence in Radiation Oncology” at Tribune Lifestyle Awards 2025 - Season 2 by the Tribune.
  • 2025: Paras Hospital, Panchkula was awarded “Pioneer in Arthroscopy & Sports Injury” by Times of India at Healthcare Pioneers, Haryana.
  • 2025: Paras Hospital, Panchkula was awarded “Healthcare Pioneers” for the “Region’s Leading Stroke Ready Hospital” by Times of India.
  • 2025: Paras Hospital, Panchkula was awarded “Healthcare Pioneers” in the category “Excellence in Renal Transplant” by Times of India.
  • 2025: Paras Hospital, Panchkula was awarded “A Leading Multi Speciality Hospital” for its outstanding contribution and excellence by Dainik Bhaskar at the “Chandigarh Eminence Awards” 2025.
  • 2025: Paras Hospital, Panchkula was awarded “Pioneer in Stem Cell Transplantation” by ZEE Punjab Haryana Himachal at “Health Conclave” 2024-2025.
  • 2025: Paras Hospital, Panchkula was awarded “Best Neuroscience Specialty Hospital” by ZEE Punjab Haryana Himachal at “Health Conclave” 2024-2025.
  • 2025: Paras Hospital, Panchkula was awarded “Excellence in Joint Replacement Surgery” at the Tribune Achievers Awards, 2025.
  • 2026: Paras Hospital, Kanpur was awarded “Excellence in Oncology Hospital of the Year” by IHW Council at the 7th edition of Cancer Summit & Awards.
  • 2026: Paras Healthcare Limited has been recognized as “Great Place to Work” by Great Place to Work, India.
  • 2026: Paras Hospital, Panchkula was awarded “Leading Hospital in Neurosciences” by the Times of India.

History and milestones

  • 2006: Established and commenced operations of its first hospital at Gurugram, Haryana.
  • 2013: Established and commenced operations of Paras HMRI Hospital, Patna, Bihar.
  • 2016: Established and commenced operations of Paras Global Hospital, Darbhanga.
  • 2017: Raised investment of Rs 2.60 billion from the investor, Commelina Ltd.
  • 2017: Performed its first bone marrow transplant procedure at Paras HMRI Hospital, Patna.
  • 2018: Established and commenced operations of Paras Hospitals, Panchkula, Haryana.
  • 2018: Performed its first kidney transplant procedure at Paras HMRI Hospital, Patna.
  • 2019: Commenced operations of two new hospitals: Paras HEC Hospital, Ranchi, Jharkhand and Paras Hospital, Udaipur, Rajasthan.
  • 2023: Expanded Paras HEC Hospital, Ranchi to 300 beds capacity and additional tertiary care.
  • 2023: Established and commenced operations of its Paras Hospitals, Srinagar, Jammu & Kashmir.
  • 2023: Performed its first bone marrow transplant procedure at Paras Hospital, Gurugram.
  • 2024: Established and commenced operations of its Paras Yash Kothari Hospital, Kanpur, Uttar Pradesh.
  • 2024: Performed its first robotic surgery at Paras Hospital, Gurugram.
  • 2024: Performed its first robotic surgery at Paras Hospital, Udaipur.
  • 2024: Performed its first liver transplant procedure at Paras Hospital, Gurugram.
  • 2024: Performed its first kidney transplant procedure at Paras Hospitals, Panchkula, Haryana.
  • 2025: Raised investment of Rs 587.00 million from the investor 360 ONE Special Opportunities Fund - Series 12.
  • 2025: Raised investment of Rs 213.00 million from the investor Axis New Opportunities AIF - Series II.

You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now